Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical TrialsJeff Sevigny, Jerome Barakos, Mehul Sampat et al.|Alzheimer Disease & Associated Disorders|2016Cited by 115
P1‐252: CONCORDANCE OF QUANTITATIVE SUVR METHODS WITH VISUAL ASSESSMENT OF FLORBETAPIR PET SCREENING RESULTSGregory Klein, Joyce Suhy, Ping Chiao et al.|Alzheimer s & Dementia|2014Cited by 2
Amyloid PET Screening for Enrollment into Alzheimer’s Disease Clinical Trials: Initial Experience in a Phase 1b Clinical Trial (P3.207)Jeff Sevigny, Jerome Barakos, Derk D. Purcell et al.|Neurology|2014Cited by 0
Amyloid pet imaging: prime 1b studyJeff Sevigny, Jerome Barakos, Joyce Suhy et al.|Neurobiology of Aging|2016Cited by 0